Manish Jha, MBBS

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Janssen Research & Development
    Topic:
    Esketamine for depression
    Date added:
    03/16/2022
    Date updated:
    03/07/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Supernus/Navitor
    Topic:
    New medication for depression
    Date added:
    03/16/2022
    Date updated:
    03/07/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Acadia
    Topic:
    Augmentation medication for depression
    Date added:
    03/16/2022
    Date updated:
    03/07/2023
    Relationship end date:
    03/01/2021
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Neurocrine
    Topic:
    New medication for anhedonia and depression
    Date added:
    03/16/2022
    Date updated:
    03/07/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Eleusis Therapeutics
    Topic:
    Psilocybin for MDD
    Date added:
    03/16/2022
    Date updated:
    03/07/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Janssen Global Services
    Topic:
    Advisory board for burden of insomani
    Date added:
    03/16/2022
    Date updated:
    03/07/2023
    Relationship end date:
    09/30/2021
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Worldwide clinical trials
    Topic:
    Chair of DSMB
    Date added:
    03/16/2022
    Date updated:
    03/07/2023
Return to 124 Ken Altshuler, MD Grand Rounds in Psychiatry: "Irritability in Adults with MDD: Clinical Significance and Potential Neurocircuit Mechanisms " (032322)